Cargando…

Diabetes in Shenzhen, China: epidemiological investigation and health care challenges

BACKGROUND: Understanding epidemiological characteristics of diabetes in a specific population will potentially benefit prevention and control of diabetes and policy–making. This study aimed to investigate the prevalence and awareness of diabetes, as well as its pharmacological, non–pharmacological...

Descripción completa

Detalles Bibliográficos
Autores principales: Yan, Xinfeng, Xia, Hui, Li, Haitao, Deng, Xiaoting, Yang, Lizhen, Zhao, Shaojuan, Zou, Jianfeng, Luo, Yi, Cao, Sijing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Edinburgh University Global Health Society 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5481894/
https://www.ncbi.nlm.nih.gov/pubmed/28685050
http://dx.doi.org/10.7189/jogh.07.011102
_version_ 1783245477769117696
author Yan, Xinfeng
Xia, Hui
Li, Haitao
Deng, Xiaoting
Yang, Lizhen
Zhao, Shaojuan
Zou, Jianfeng
Luo, Yi
Cao, Sijing
author_facet Yan, Xinfeng
Xia, Hui
Li, Haitao
Deng, Xiaoting
Yang, Lizhen
Zhao, Shaojuan
Zou, Jianfeng
Luo, Yi
Cao, Sijing
author_sort Yan, Xinfeng
collection PubMed
description BACKGROUND: Understanding epidemiological characteristics of diabetes in a specific population will potentially benefit prevention and control of diabetes and policy–making. This study aimed to investigate the prevalence and awareness of diabetes, as well as its pharmacological, non–pharmacological and primary care management in Shenzhen, China. METHODS: A cross–sectional study was conducted. We employed multistage cluster random sampling methods to select the participants. Face–to–face interview surveys were conducted to collect data. A total of 1676 participants completed the survey. RESULTS: We found that the prevalence of diabetes was 4.8%. The prevalence of impaired fasting blood glucose was 6.0%. The prevalence rates of both diabetes and impaired fasting blood glucose increased with age (P < 0.001), whereas hypertension was strongly associated with diabetes only (odds ratio (OR) = 1.93, 95% confidence interval (CI) 1.15–3.22). The awareness of diabetes was poor (51.9%) and 54.3% of diabetic patients were not being treated pharmacologically. Less than one–third of diabetic patients were undergoing non–pharmacological treatments. Primary care management of diabetes was recorded for only 11.1% of the patients. CONCLUSIONS: Although diabetes prevalence in Shenzhen is about a half that of the Chinese average, high prevalence of impaired fasting blood glucose imposes a public health threat and burden to the health care system. Approximately half of the subjects with diabetes are undiagnosed. Our findings highlight the need of public health efforts for primary and secondary prevention, as well as early detection of diabetes. Primary care may be crucial an improved access to medical services and better management of diabetes.
format Online
Article
Text
id pubmed-5481894
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Edinburgh University Global Health Society
record_format MEDLINE/PubMed
spelling pubmed-54818942017-07-06 Diabetes in Shenzhen, China: epidemiological investigation and health care challenges Yan, Xinfeng Xia, Hui Li, Haitao Deng, Xiaoting Yang, Lizhen Zhao, Shaojuan Zou, Jianfeng Luo, Yi Cao, Sijing J Glob Health Research Theme 7: Health Transitions in China BACKGROUND: Understanding epidemiological characteristics of diabetes in a specific population will potentially benefit prevention and control of diabetes and policy–making. This study aimed to investigate the prevalence and awareness of diabetes, as well as its pharmacological, non–pharmacological and primary care management in Shenzhen, China. METHODS: A cross–sectional study was conducted. We employed multistage cluster random sampling methods to select the participants. Face–to–face interview surveys were conducted to collect data. A total of 1676 participants completed the survey. RESULTS: We found that the prevalence of diabetes was 4.8%. The prevalence of impaired fasting blood glucose was 6.0%. The prevalence rates of both diabetes and impaired fasting blood glucose increased with age (P < 0.001), whereas hypertension was strongly associated with diabetes only (odds ratio (OR) = 1.93, 95% confidence interval (CI) 1.15–3.22). The awareness of diabetes was poor (51.9%) and 54.3% of diabetic patients were not being treated pharmacologically. Less than one–third of diabetic patients were undergoing non–pharmacological treatments. Primary care management of diabetes was recorded for only 11.1% of the patients. CONCLUSIONS: Although diabetes prevalence in Shenzhen is about a half that of the Chinese average, high prevalence of impaired fasting blood glucose imposes a public health threat and burden to the health care system. Approximately half of the subjects with diabetes are undiagnosed. Our findings highlight the need of public health efforts for primary and secondary prevention, as well as early detection of diabetes. Primary care may be crucial an improved access to medical services and better management of diabetes. Edinburgh University Global Health Society 2017-06 2017-06-18 /pmc/articles/PMC5481894/ /pubmed/28685050 http://dx.doi.org/10.7189/jogh.07.011102 Text en Copyright © 2017 by the Journal of Global Health. All rights reserved. http://creativecommons.org/licenses/by/4.0/ This work is licensed under a Creative Commons Attribution 4.0 International License.
spellingShingle Research Theme 7: Health Transitions in China
Yan, Xinfeng
Xia, Hui
Li, Haitao
Deng, Xiaoting
Yang, Lizhen
Zhao, Shaojuan
Zou, Jianfeng
Luo, Yi
Cao, Sijing
Diabetes in Shenzhen, China: epidemiological investigation and health care challenges
title Diabetes in Shenzhen, China: epidemiological investigation and health care challenges
title_full Diabetes in Shenzhen, China: epidemiological investigation and health care challenges
title_fullStr Diabetes in Shenzhen, China: epidemiological investigation and health care challenges
title_full_unstemmed Diabetes in Shenzhen, China: epidemiological investigation and health care challenges
title_short Diabetes in Shenzhen, China: epidemiological investigation and health care challenges
title_sort diabetes in shenzhen, china: epidemiological investigation and health care challenges
topic Research Theme 7: Health Transitions in China
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5481894/
https://www.ncbi.nlm.nih.gov/pubmed/28685050
http://dx.doi.org/10.7189/jogh.07.011102
work_keys_str_mv AT yanxinfeng diabetesinshenzhenchinaepidemiologicalinvestigationandhealthcarechallenges
AT xiahui diabetesinshenzhenchinaepidemiologicalinvestigationandhealthcarechallenges
AT lihaitao diabetesinshenzhenchinaepidemiologicalinvestigationandhealthcarechallenges
AT dengxiaoting diabetesinshenzhenchinaepidemiologicalinvestigationandhealthcarechallenges
AT yanglizhen diabetesinshenzhenchinaepidemiologicalinvestigationandhealthcarechallenges
AT zhaoshaojuan diabetesinshenzhenchinaepidemiologicalinvestigationandhealthcarechallenges
AT zoujianfeng diabetesinshenzhenchinaepidemiologicalinvestigationandhealthcarechallenges
AT luoyi diabetesinshenzhenchinaepidemiologicalinvestigationandhealthcarechallenges
AT caosijing diabetesinshenzhenchinaepidemiologicalinvestigationandhealthcarechallenges